Researchers see some promise in ibogaine, a well-known hallucinogen, and related compounds
China has been using colistin to speed growth of farm animals
Millions of patients depend on a rare radioactive form of one element to scan them for disease. But the old nuclear reactors that make it are shutting down
The small molecules cleared and prevented tau buildup in mice and monkeys
When LSD binds to serotonin receptors, it pulls a "lid" closed behind it, locking it in place for hours, and explaining its long-lasting effects. Christopher Intagliata reports. ...
Blood tests can be highly unreliable
Funnel web venom needed after a dry spell triggers more bites
A few early-stage clinical trials are underway
Scientific American executive editor Fred Guterl talks with Pres. Obama’s science advisor, John Holdren, about climate science, space travel, the issue of reproducibility in science, the brain initiative and more...
A virus that infects bacteria listens to messages from its relatives when deciding how to attack its hosts
Early targets include Nipah virus and Middle East respiratory syndrome
Committee mentioned in a Trump meeting last week could scare people away from protective immunizations, scientists say
The Jekyll-and-Hyde behavior of astrocytes may point the way to treatments for degenerative diseases such as ALS, Alzheimer’s and MS
Pulitzer Prize–winning N.Y.U. historian David Oshinsky, director of the Division of Medical Humanities at the N.Y.U. Langone Medical Center, talks about his latest book, Bellevue: Three Centuries of Medicine and Mayhem at America’s Most Storied Hospital ...
Critics have portrayed ECT as a form of medical abuse. Yet many psychiatrists, and more importantly, patients, consider it to be safe and effective. Few medical treatments have such disparate images...
The “nightmare bacteria” could fend off 26 different drugs
Where did it come from? How do organisms use it without self-destructing? And what else can it do?
Reforms have been proposed at the federal and state level
His anti-vaccine credentials date back to 2005
For-profit companies use our anonymized medical data in a huge secondary market. Advances in computing make it increasingly possible for outsiders to identify people from among the hundreds of millions of patients in dossiers, putting intimate secrets about our bodies and minds at risk...